Cyclerion Therapeutics, Inc. (24)
Browse by Contract Category
Contracts
-
Cyclerion Therapeutics, Inc. Executive Severance Plan
(Filed With SEC on August 9, 2022)
-
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault
(Filed With SEC on May 4, 2022)
-
Lease Termination Agreement, dated as of April 30, 2021, by and between BMR-Rogers Street LLC and the Company
(Filed With SEC on May 4, 2021)
-
Common Stock Purchase Agreement dated as of July 29, 2020, by and between Cyelerion Therapeuties, Inc. and he Investors Named Therein
(Filed With SEC on August 3, 2020)
-
Intellectual Property License Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)
-
Development Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)
-
Non-Employee Director Compensation Plan (amended and restated as of December 17, 2021)
(Filed With SEC on May 4, 2022)
-
Employment Agreement, effective April 29, 2019, by and between Cyclerion GmbH and Andreas Busch
(Filed With SEC on May 4, 2022)
-
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on February 24, 2022)
-
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on February 25, 2021)
-
Open Market Sale AgreementSM, dated September 3, 2020, by and between Cyclerion Therapeutics, Inc. and Jefferies LLC
(Filed With SEC on September 3, 2020)
-
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 12, 2020)
-
First Amendment to and Partial Termination of Lease Agreement Lease, dated April 1, 2019, by and between BMR-Rogers Street LLC and the Company
(Filed With SEC on March 5, 2020)
-
Cyclerion Therapeutics, Inc. Executive Severance Plan
(Filed With SEC on September 25, 2019)
-
Non-Employee Director Compensation Plan (effective June 1, 2019)
(Filed With SEC on August 12, 2019)
-
Transition Services Agreement, dated as of April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc
(Filed With SEC on April 2, 2019)
-
Separation Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)
-
Lease, dated April 1, 2019, by and between BMR-Rogers Street LLC and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)
-
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and William Huyett
(Filed With SEC on April 2, 2019)
-
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Mark G. Currie, Ph.D
(Filed With SEC on April 2, 2019)
-
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Peter M. Hecht, Ph.D
(Filed With SEC on April 2, 2019)
-
Employee Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)
-
Tax Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)
-
Transition Services Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
(Filed With SEC on April 2, 2019)